Originally published as Covington E-Alert on March 1st, 2012
Today the European Commission published its long awaited proposal for the revision of the so-called Transparency Directive. The Directive lays down procedural guarantees for the systems that regulate the pricing and reimbursement (“P&R”) of medicines in the thirty EU and EEA Member States. The revision aims at modernizing the current rules, which date back to 1989 and no longer reflect the practical realities of the national schemes.
The proposal will now be reviewed by the European Parliament (EP) and the Council, the body grouping the Member States. It is likely that it will be significantly amended before it is finally adopted. Adoption is foreseen during the course of 2013 or in early 2014 and the new rules may take effect one year later.
Read the complete article here